Prelude Therapeutics
PRLD
#9255
Rank
NZ$0.17 B
Marketcap
NZ$2.80
Share price
-1.21%
Change (1 day)
67.61%
Change (1 year)

Market capitalization of Prelude Therapeutics (PRLD)

Market cap: NZ$0.17 Billion

As of December 2025 Prelude Therapeutics has a market cap of NZ$0.17 Billion. This makes Prelude Therapeutics the world's 9255th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Prelude Therapeutics from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.17 B34.71%
2024NZ$0.13 B-64.68%
2023NZ$0.37 B-18.66%
2022NZ$0.45 B-47.54%
2021NZ$0.86 B-79.98%
2020NZ$4.33 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Prelude Therapeutics was reported to be:

NZ$0.17 Billion
by Nasdaq info icon info icon
NZ$0.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.62 B 820.95%๐Ÿ‡บ๐Ÿ‡ธ USA